PCTC
ELV icon

Perkins Coie Trust Company’s Elevance Health ELV Stock Holding History

Perkins Coie Trust Company’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$434 – 345
2025
Q1 		$434 Buy
+1
New +$401 ﹤0.01% 354
2023
Q4 		– Sell
-15
Closed -$6.53K – 388
2023
Q3 		$6.53K Buy
+15
New +$6.8K ﹤0.01% 259
2020
Q3 		– Sell
-3
Closed -$1K – 271
2020
Q2 		$1K Hold
3
– – ﹤0.01% 266
2020
Q1 		$1K Buy
+3
New +$818 ﹤0.01% 294

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Perkins Coie Trust Company's ELV Position: Q2 2025 in Review

Perkins Coie Trust Company sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 1 share — an estimated $434 sold.

Perkins Coie Trust Company first reported a position in ELV in Q1 2020 and held it in 4 quarters. The position peaked at $6.53K in Q3 2023. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Perkins Coie Trust Company reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Perkins Coie Trust Company sold 1 Elevance Health share in Q2 2025, an estimated $434.
  • Perkins Coie Trust Company first reported a position in Elevance Health in Q1 2020 and held it in 4 quarters.
  • Perkins Coie Trust Company's Elevance Health position peaked at $6.53K in Q3 2023.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Perkins Coie Trust Company's 13F filing for Q2 2025, filed 10 Jul 2025.